Media2017-10-24T20:47:01+00:00

Forge achieves carb-x milestone to advance its lpxc antibiotic to treat infections caused by the world’s deadliest ‘superbugs’

-Technical milestone achievement and program advancement from initial round of ‘Powered by CARB-X’ products- San [...]

August 1st, 2018|

Forge announces oral presentation on development of novel antibiotics at the 28th annual ECCMID meeting

San Diego, California, April 9, 2018 – Forge Therapeutics, Inc. (Forge), a biotechnology company developing [...]

April 9th, 2018|

Forge Co-founder Presents New Approaches to Treat Infections at the 255th American Chemical Society National Meeting

San Diego, California, March 19, 2018 – Forge Therapeutics, Inc. (Forge), a biotechnology company developing [...]

March 19th, 2018|

Categories

Archives

Recent Tweets